95 related articles for article (PubMed ID: 17049770)
41. Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part I: Physicochemical characterisation.
Myschik J; Eberhardt F; Rades T; Hook S
J Drug Target; 2008 Apr; 16(3):213-23. PubMed ID: 18365883
[TBL] [Abstract][Full Text] [Related]
42. Oxidative stress can affect the gene silencing effect of DOTAP liposome in an in vitro translation system.
Umakoshi H; Tanabe T; Suga K; Bui HT; Shimanouchi T; Kuboi R
Int J Biol Sci; 2011 Mar; 7(3):253-60. PubMed ID: 21448335
[TBL] [Abstract][Full Text] [Related]
43. Immunostimulating complexes incorporating Eimeria tenella antigens and plant saponins as effective delivery system for coccidia vaccine immunization.
Berezin VE; Bogoyavlenskiy AP; Tolmacheva VP; Makhmudova NR; Khudyakova SS; Levandovskaya SV; Omirtaeva ES; Zaitceva IA; Tustikbaeva GB; Ermakova OS; Aleksyuk PG; Barfield RC; Danforth HD; Fetterer RH
J Parasitol; 2008 Apr; 94(2):381-5. PubMed ID: 18564738
[TBL] [Abstract][Full Text] [Related]
44. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines.
Yan W; Chen W; Huang L
Mol Immunol; 2007 Jul; 44(15):3672-81. PubMed ID: 17521728
[TBL] [Abstract][Full Text] [Related]
45. Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
Rönnberg B; Fekadu M; Behboudi S; Kenne L; Morein B
Vaccine; 1997 Dec; 15(17-18):1820-6. PubMed ID: 9413088
[TBL] [Abstract][Full Text] [Related]
46. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying.
Hinrichs WL; Manceñido FA; Sanders NN; Braeckmans K; De Smedt SC; Demeester J; Frijlink HW
Int J Pharm; 2006 Mar; 311(1-2):237-44. PubMed ID: 16442758
[TBL] [Abstract][Full Text] [Related]
47. Cationic liposome colloidal stability in the presence of guar derivatives suggests depletion interactions may be operative in artificial tears.
Khanal A; Cui Y; Zhang L; Pelton R; Ren Y; Ketelson H; Davis J
Biomacromolecules; 2010 Sep; 11(9):2460-4. PubMed ID: 20690592
[TBL] [Abstract][Full Text] [Related]
48. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
[TBL] [Abstract][Full Text] [Related]
49. Quil A and ISCOMs as adjuvants for midgut membrane antigens of Boophilus microplus.
Jackson LA; Opdebeeck JP
Appl Parasitol; 1994 Jun; 35(2):87-98. PubMed ID: 8087157
[TBL] [Abstract][Full Text] [Related]
50. Optimal conditions for labelling of 3T3 fibroblasts with magnetoliposomes without affecting cellular viability.
Soenen SJ; Baert J; De Cuyper M
Chembiochem; 2007 Nov; 8(17):2067-77. PubMed ID: 17943707
[TBL] [Abstract][Full Text] [Related]
51. The role of cholesterol and structurally related molecules in enhancing transfection of cationic liposome-DNA complexes.
Zidovska A; Evans HM; Ahmad A; Ewert KK; Safinya CR
J Phys Chem B; 2009 Apr; 113(15):5208-16. PubMed ID: 19354307
[TBL] [Abstract][Full Text] [Related]
52. Mannosylated saponins based on oleanolic and glycyrrhizic acids. Towards synthetic colloidal antigen delivery systems.
Daines AM; Greatrex BW; Hayman CM; Hook SM; McBurney WT; Rades T; Rendle PM; Sims IM
Bioorg Med Chem; 2009 Jul; 17(14):5207-18. PubMed ID: 19502067
[TBL] [Abstract][Full Text] [Related]
53. In vivo studies of dialkynoyl analogues of DOTAP demonstrate improved gene transfer efficiency of cationic liposomes in mouse lung.
Fletcher S; Ahmad A; Perouzel E; Heron A; Miller AD; Jorgensen MR
J Med Chem; 2006 Jan; 49(1):349-57. PubMed ID: 16392819
[TBL] [Abstract][Full Text] [Related]
54. Polyion-induced aggregation of lipidic-coated solid polystyrene spheres: the many facets of complex formation in low-density colloidal suspensions.
Zuzzi S; Cametti C; Onori G
Langmuir; 2008 Jun; 24(12):6044-9. PubMed ID: 18484758
[TBL] [Abstract][Full Text] [Related]
55. In vitro cutaneous application of ISCOMs on human skin enhances delivery of hydrophobic model compounds through the stratum corneum.
Madsen HB; Ifversen P; Madsen F; Brodin B; Hausser I; Nielsen HM
AAPS J; 2009 Dec; 11(4):728-39. PubMed ID: 19862629
[TBL] [Abstract][Full Text] [Related]
56. ISCOMs: an adjuvant with multiple functions.
Sjölander A; Cox JC; Barr IG
J Leukoc Biol; 1998 Dec; 64(6):713-23. PubMed ID: 9850152
[TBL] [Abstract][Full Text] [Related]
57. Adjuvanticity and ISCOM formation by structurally diverse saponins.
Bomford R; Stapleton M; Winsor S; Beesley JE; Jessup EA; Price KR; Fenwick GR
Vaccine; 1992; 10(9):572-7. PubMed ID: 1502835
[TBL] [Abstract][Full Text] [Related]
58. Palladium nanotubes formed by lipid tubule templating and their application in ethanol electrocatalysis.
Wang Y; Ma S; Su Y; Han X
Chemistry; 2015 Apr; 21(16):6084-9. PubMed ID: 25766748
[TBL] [Abstract][Full Text] [Related]
59. Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems.
Sanina N; Chopenko N; Mazeika A; Kostetsky E
Biomed Res Int; 2017; 2017():4389525. PubMed ID: 28808657
[TBL] [Abstract][Full Text] [Related]
60. Influenza virus ISCOMs: biochemical characterization.
Sundquist B; Lövgren K; Höglund S; Morein B
Vaccine; 1988 Feb; 6(1):44-8. PubMed ID: 3354257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
